Home > Boards > US OTC > Delisted >

Pharm Control Ltd. (fka PMCL)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/29/2018 5:07:08 PM - Followers: 133 - Board type: Free - Posts Today: 0

 LATEST NEWS 

 

 PMCL Investors Demand Justice ... Or Else !!!


April 28, 2009 

Ontario Securities Commission (OSC) Notice

IN THE MATTER OF IRWIN BOOCK, STANTON DEFREITAS, JASON WONG, SAUDIA ALLIE, ALENA DUBINSKY, ALEX KHODJIAINTS, SELECT AMERICAN TRANSFER CO., LEASESMART, INC., ADVANCED GROWING SYSTEMS, INC., INTERNATIONAL ENERGY LTD., NUTRIONE CORPORATION, POCKETOP CORPORATION, ASIA TELECOM LTD., PHARM CONTROL LTD., CAMBRIDGE RESOURCES CORPORATION, COMPUSHARE TRANSFER CORPORATION, FEDERATED PURCHASER, INC., TCC INDUSTRIES, INC., FIRST NATIONAL ENTERTAINMENT CORPORATION, WGI HOLDINGS, INC. and ENERBRITE TECHNOLOGIES GROUP

TORONTO – The Commission issued an Order which provides that the hearing of this matter on the merits shall be held on Monday, October 19, 2009 through to Friday, November 13, 2009, excluding Wednesday, November 11, 2009, commencing each day at 10:00 a.m. at the offices of the Commission on the 17th floor, 20 Queen Street West in Toronto.

OFFICE OF THE SECRETARY
JOHN P. STEVENSON, SECRETARY

URL: http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20090428_boocki.jsp

A copy of the Order dated April 22, 2009 is available at: 

http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090422_boocki.jsp

http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090422_boocki.pdf


For Investor Inquiries:

OSC Contact Centre
416-593-8314
1-877-785-1555 (Toll Free)

For OSC Media Inquiries:

Wendy Dey - Director, Communications & Public Affairs - (416) 593-8120
Laurie Gillett - Manager, Public Affairs - (416) 595-8913
Carolyn Shaw-Rimmington - Assistant Manager, Public Affairs - (416) 593-2361

 All OSC releases for PMCL: http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_p_index.jsp


Stanton DeFreitas - OSC Press Releases: http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_d_index.jsp (scroll down to "De Freitas") 

June 24: OSC Order for Stanton DeFreitas (Trader):
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20080624_defreitas.jsp

June 25: OSC Notice for Stanton DeFreitas (Trader): http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20080625_defreitas.jsp


Who is Stanton DeFreitas ?

S.B.J. DeFreitas is a financial and strategy consultant to various high net worth individuals and business enterprises across the globe with a focus on North America and the OECS. His background in the North American banking, brokerage and insurance sectors, estate, tax and strategic planning, coupled with his concentration on the offshore industry make him a multi-faceted consultant who can contribute to a variety of assignments for any client.

DeFreitas and Associates: http://www.defreitas-consulting.com/practitioner_sbj.htm


February 27, 2009

Securities and Exchange Commission (SEC) Order

SEC Suspends Trading of Imark Technologies, Inc. (n/k/a Pharm Control Ltd.) on Feb 27, 2009

"It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Imark Technologies, Inc. (n/k/a Pharm Control Ltd.) because it has not filed any periodic reports since the period ended March 31, 1998."

http://www.sec.gov/litigation/suspensions.shtml

http://www.sec.gov/litigation/suspensions/2009/34-59466.pdf

http://www.sec.gov/litigation/suspensions/2009/34-59466-o.pdf

 

Ontario Securities Commission (OSC) Notice

IN THE MATTER OF Irwin Boock, Stanton DeFreitas, Jason Wong, Saudia Allie, Alena Dubinsky, Alex Khodjiaints, Select American Transfer Company, LEASESMART, INC., ADVANCED GROWING SYSTEMS, INC., INTERNATIONAL ENERGY LTD., NUTRIONE CORP., POCKETOP CORP., ASIA TELECOM LTD., PHARM CONTROL LTD., CAMBRIDGE RESOURCES CORP., COMPUSHARE TRANSFER CORP., FEDERATED PURCHASER, INC., TCC INDUSTRIES, INC., FIRST NATIONAL ENTERTAINMENT CORP., WGI HOLDINGS, INC. and ENERBRITE TECHNOLOGIES GROUP

The Commission issued an Order adjourning the hearing until February 17, 2009 at 3:00 p.m. for the purpose of having a pre-hearing conference on that date.

Source: http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20090206_boocki.jsp 


January 20, 2009

Ontario Securities Commission (OSC) Order

Temporary Orders in respect of the Corporate Respondents and in respect of Boock and DeFreitas were extended until the conclusion of this proceeding or until further order of the Commission with an exception allowing Boock to trade in his existing RRSP account in securities that are listed on the Toronto Stock Exchange or New York Stock Exchange, provided that Boock provides to Staff copies of the monthly account statements for the RRSP account on a timely basis.

Submissions from counsel for Staff of the Commission, counsel to Boock, DeFreitas, and Enerbrite Technologies, respectively, and from Alena Dubinsky and Alex Kodjiaints on their own behalf, and upon being advised that Jason Wong through his counsel does not object to the order being sought by Staff, with no one appearing for the balance of the Individual and Corporate Respondents.

The hearing is adjourned until February 17, 2009 at 3 p.m. for the purpose of having a pre-hearing conference on that date.

Source: http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090120_boocki.jsp

PDF: http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090120_boocki.pdf


January 12, 2009

Shareholders Discovered Pharm Control Ltd Web Site is Shut Down: http://www.control24online.com

Analsyis of Pharm Control Ltd Web Sites Using GoDaddy.com: http://investorshub.advfn.com/boards/read_msg.asp?message_id=23093369

Diabetes product, Control 24™, is available at alleged CEO Dr. Lee's web site:  http://www.leejaseng.com/diabetes_news/diabetes_safe.htm

Control 24™
FDA Registration No: 2022038
DEA Registration No: RB0177877

FDA Microbiological Evaluation Test Results:
http://www.leejaseng.com/diabetes_news/diabetes_micro_evaluation.jpg
FDA Supplement Facts Test Results: http://www.leejaseng.com/diabetes_news/diabetes_supplement_facts.jpg
FDA Acute Oral Toxicity Test Results:
http://www.leejaseng.com/diabetes_news/diabetes_toxicity.jpg

CEO Dr. Lee's web site: http://www.leejaseng.com 

CEO Dr. Lee's contact info: http://www.leejaseng.com/company/company.htm

Note: Dr. Lee is CEO of Pharm Control Ltd. according to 2007 press releases. 


CEO Profile: Dr. Sang Hee Lee

Dr. Lee continues to practice medicine in Canada and has brought with him 3 generations of knowledge and expertise in Oriental Medicine. He is now the mastermind behind the new line of herbal supplements manufactured by S. H. Herb America Inc. Within his first year, his patients began to multiply rapidly as his Natural Dietary Supplements gained popularity. He has now treated tens of thousands of patients internationally.

Dr. Lee's Medical Practice: http://www.leejaseng.com/company/company.htm

Shareholder Conversation with CEO Dr. Lee:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=18237523


CEO Dr. Sang Hee Lee's Manufacturing Facilities

S. H. Herb America Inc.
1940 West Olympic Boulevard
Los Angeles, CA 90006-3704
Phone: (213) 383-1010
Canada business record date: 01/30/2007

S. H. Herb America Canada Inc.
Toronto, Ontario M2N 5P2
CANADA

Note: Pharm Control Ltd has not confirmed the association of this web site with the company or Dr. S.H. Lee. iHub members have tried to contact Dr. Lee by email at info@leejaseng.com.


June 24, 2008 - OSC Temporary Trading Halt Order

Upon hearing submissions from counsel for Staff of the Commission and with the consent of NutriOne and the consent of Pharm Control, with no one appearing for David Watson, Nathan Rogers, Amy Giles, John Sparrow, LeaseSmart, Cambridge Resources, Advanced Growing Systems, The Bighub.Com, Universal Seismic, Pocketop, International Energy, Select American and Asia Telecom; The Commission is of the opinion that it is in the public interest to make this order:

IT IS ORDERED THAT: the hearing to extend the Temporary Orders, as modified, is adjourned until September 9, 2008 at 1:00 p.m.; and pursuant to subsection 127(8) of the Act, the Temporary Orders, as modified, are extended until September 10, 2008 or until further order of the Commission.

Pharm Control Ltd - OSC Press Releases: http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_p_index.jsp (scroll down to "Pharm Control Ltd")

June 24: OSC Order for PMCL:
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20080624_select_american.jsp

June 25: OSC Notice for PMCL:
http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20080625_select_american.jsp


Company Mission Statement

Pharm Control Ltd. is devoted to discovering and developing new remedies that will enable patients to live longer, healthier, and more productive lives.  Pharm Control's mission is to develop natural and no side effect supplements to support a normal way of life with Diabetes, High Cholesterol and High Blood Pressure.

Herbal Products and Pipeline

1. Diabetes Solution: Control 24™ - Available Now at Online Store -
http://www.control24online.com
2. High Cholesterol Solution: SAPO-Q™ - Available Now at Online Store - 
http://www.control24online.com
3. High Blood Pressure Solution: Developing - See PR on April 27, 2007
4. Dr. Lee's Medical Practice & Herbal Solutions:
http://www.leejaseng.com/company/company.htm


Weekly Share Price Analysis



Company Info

Pharm Control Ltd
47 Redwillow Drive
Toronto, Ontario, M3A 2K8
CANADA

Web:
http://www.control24online.com
Phone: (416) 710-5136 (Company Office)
Phone: (416) 562-6030 (Company Office)
Phone: (212) 252-4521 (Investor Relations)
Fax: (416) 391-3802

State Of Incorporation: Delaware, USA
Canada Business Number: 861-16-2253


Company Share Structure

Outstanding Shares: 40,832,508 (as of Dec 12, 2006)
Management Owned Shares: 30,000,000 (Estimated)
Anticipated Outstanding Shares After Future 8:5 Forward Split: 65,332,013 (May 11, 2007 PR)

iHub Member Survey: 85 shareholders, 25,652,730 shares - http://investorshub.advfn.com/boards/read_msg.asp?message_id=24265089

Stock Transfer Agent

First American Stock Transfer
706 East Bell Road, Suite 202
Phoenix, AZ 85022-6642
Phone: (602) 485-1346
Fax: (602) 788-0423
POC: Salli A. Marinov
Email: Salli@firstamericanstock.com
Website:
http://www.firstamericanstock.com

Business Description

Pharm Control Ltd. is a leading all natural medicine, research and development company devoted to inventing herbal-based remedies that allow patients to live longer, healthier, and more productive lives. Its founders have invested over 10 years of research discovering and developing new and effective, non-synthetic ways to fight and relieve disorders and sickness in the modern world.

Mission Statement

Pharm Control Ltd. is devoted to discovering and developing new remedies that will enable patients to live longer, healthier, and more productive lives. Pharm Control's mission is to develop natural and no side effect supplements to support a normal way of life with Diabetes, High Cholesterol and High Blood Pressure.

Company Officers

Dr. Sang Hee Lee: President, CEO, http://www.leejaseng.com/company/company.htm
Eugene Kron: Vice President, Press Release POC: (212) 252-4521
Yevgen Konaryev: Vice President, Director
Jae Ho Kim: Vice President, Director:
http://www.henryfordhealth.org/11486.cfm
Ho Sup Song: Secretary, Treasurer:
http://www.keri.org/eng/about/org_supt03.asp

Note: The association of the above 3 web sites with PMCL company officers has not been confirmed to date. Provided for research purposes only.

Company Email:

General Company Info: contact@control24online.com
Product Info: info@control24online.com
CEO Sang Hee Lee: info@leejaseng.com, jasengca@hotmail.com
VP Eugene Kron: pmclinfo@yahoo.com, pharmcontrol@gmail.com
Stock Transfer Agent: Salli@firstamericanstock.com


Company Products and Pipeline

1. Diabetes Solution: Control 24™ - Available Now at Online Store -
http://www.control24online.com
2. High Cholesterol Solution: SAPO-Q™ - Available Now at Online Store -
http://www.control24online.com
3. High Blood Pressure Solution: Developing - See PR on April 27, 2007
4. Dr. Lee's Medical Practice & Herbal Solutions:
http://www.leejaseng.com/company/company.htm

Diabetes Soltuion: Control 24™ is Available Now

Control 24™: Learn more about patient test results, testimonials and an interview with CEO Dr. Lee: http://www.leejaseng.com/diabetes_news/diabetes_news.htm

FDA Testing: Herb/food supplement testing successful at the Bio-Science Research Institute, a FDA registered testing laborartory in Chino, California -
http://www.bio-scienceresearch.com

Dr. Lee's Medical Practice:
http://www.leejaseng.com/company/company.htm


High Cholesterol Solution: SAPO-Q™ is Available Now

SAPO-Q™: the all natural food supplement, helps to reduce cholesterol levels of adults suffering from high levels of cholesterol. It is 100% natural and side effect free, fully made of Oriental herbs which have several thousands years of tradition and usage.

The Bio-Science Research Institute Inc. in FDA adjudges SAPO-Q to be free from acute oral toxicants. Learn more about this Cholesterol Care Natural Solution now available for purchase at the Online Store:

FDA Testing: Herb/food supplement testing successful at the Bio-Science Research Institute, a FDA registered testing laborartory in Chino, California -
http://www.bio-scienceresearch.com


High Blood Pressure Solution: Herbal-Based Product Available Soon

"Pharm Control is proud to announce that the company is intensely researching and developing a new product that is an all-natural medication to reduce blood pressure for high blood pressure sufferers. The Company hopes to bring this product to market shortly both in Europe and North America where the market for such a product is high." (April 18, 2007 PR)


Company Info on the Web

Pink Sheets:
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=PMCL
OTCBB:
http://www.otcbb.com/asp/quote_module.asp?qm_page=90408&symbol=PMCL
Yahoo:
http://finance.yahoo.com/q?s=PMCL.PK
Qwoter:
http://www.qwoter.com/profiles/item.php?id=34&dir=1


Announced Stock Listing Changes

Company name: Natural Medicines Inc.
Stock symbol: NATM.PK
CUSIP: 63889A101

European IPO: Natural Medicines AG - New European Distribution Company (Feb 21, 2007 PR)

Shareholder Dividend: "one new share of Natural Medicines AG for every three shares of Pharm Control" (May 16, 2007 PR)

Asian IPO: "The Company is looking into listing the (stock) for trading in overseas markets with an emphasis on South East Asia." (April 27, 2007 PR)

iHub Member Research:
http://www.investorshub.com/boards/read_msg.asp?message_id=19279195

iHub Member Comments on Potential PMCL Sales in South Korea:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=18196450


WHY ARE DISCOUNT BROKERS BLOCKING BUY ORDERS AND ONLY ALLOWING SELL ORDERS OF PMCL SHARES ?

Temporary Trading Halt Order by OSC and DTC

Source:
http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20071218_watsond.jsp


Ontario Securities Commission (OSC) Temporary Trading Halt Order (May 22, 2007)

"Select American, acting as the transfer agent to these companies, may have issued false share certificates for trading in securities of these issuers in the over-the-counter securities market via the Pink Sheets."
Source:
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20070522_select-american.jsp


Pharm Control Ltd (PMCL) Responds to OSC Allegations (May 25, 2007)

"The Management of Pharm Control Ltd. would like to notify all shareholders that it vehemently denies any allegations made by the Ontario Securities Commission (OSC) in its Press Release.  The Company will have its lawyers vigorously pursue all avenues to clarify these matters on behalf of its shareholders."
Source:
http://biz.yahoo.com/iw/070525/0257794.html


Depository Trust Company (DTC) Response to OSC Temporary Order (May 25, 2007)

Source:
http://www.dtc.org/impNtc/ope/ope_1641.pdf


Ontario Securities Commission (OSC) Temporary Trading Halt Order (June 25, 2007)

"Trading in any securities by Select American Transfer Co. ("Select American") shall cease. Submissions from counsel representing Pharm Control have consented to the extension of the June 1st Order until September 28, 2007."

http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20070625_selectamerican.jsp (June 25, 2007)

NOTE: Fidelity and Bank of America are the only known discount brokers that are allowing people to buy PMCL shares as of Septbember 24, 2007.


OSC Contact Information

Phone: 1-877-785-1555 (Toll Free)
Email: inquiries@osc.gov.on.ca
News Releases:
http://www.osc.gov.on.ca/Media/NewsReleases/2007/nr_2007_index.jsp


2007 COMPANY PRESS RELEASES - APPARENTLY ALL COMPLETELY FALSE & MISLEADING STATEMENTS

Market Wire
:
http://www.marketwire.com/mw/search.do?params=&grpSearch=C&companyid=35770
Yahoo:
http://finance.yahoo.com/q?s=PMCL.PK
Qwoter:
http://www.qwoter.com/profiles/item.php?id=34&dir=1


May 25, 2007: Pharm Control Responds to OSC Allegations (Market Wire)

The Management of Pharm Control would like to notify all shareholders that it vehemently denies any allegations made by the Ontario Securities Commission (OSC) in its Press Release.  The Company will have its lawyers vigorously pursue all avenues to clarify these matters on behalf of its shareholders.


May 16, 2007: Pharm Control Shareholder Update (Market Wire)

The Board of Directors of Pharm Control has decided to dividend out to shareholders one new share of Natural Medicines AG for every three shares of Pharm Control held by shareholders of record on Friday, July 13, 2007. Discussions with European investment bankers have revealed to Company management that the anticipated trading level for the new European entity will be in the area of 0.25 Euros. This dividend will be paid after the 8 new for 5 old dividend payment of Pharm Control at the end of June. Pharm Control's management anticipates the name change and CUSIP number change to become effective any day now and will follow up with another shareholder update along with the name of the new transfer agent once all is completed.


May 11, 2007: Pharm Control Shareholder Update (Market Wire)

The Board of Directors of Pharm Control is proud to announce that they have decided to reward patient shareholders with a forward stock split whereby shareholders of record on June 29, 2007 will receive eight (8) new shares for every five (5) shares they hold. The company intends to proceed with the previously announced stock spin-off of the European distribution company after this dividend is completed. Pharm Control is still in the process of completing its change of transfer agents while awaiting the approval of the new stock symbol by the NASD.


May 4, 2007: Pharm Control Announces Formation of New Marketing and Distribution Unit (M2 PRESSWIRE via COMTEX)

Pharm Control Ltd is pleased to announce that after discussions with European investment bankers, the Company has decided to form a new corporation called Natural Medicines AG, which will serve as the Company's marketing and distribution arm of in Europe.

The Company intends to spin off by way of stock dividend ownership of this new entity to its shareholders. This will be done after the Company makes the necessary arrangements to list this company on a European stock exchange in the coming months.

Further information including dividend dates will be forthcoming.

CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. Tel: +1 212 252 4521 e-mail: pmclinfo@yahoo.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to info@m2.com.


April 27, 2007: Pharm Control Shareholder Update (Market Wire)

Pharm Control would like to update its shareholders by advising that the Company anticipates the name change to Natural Medications Inc., the new CUSIP and new symbol to be processed by some time in early May 2007. In addition, the Board of Directors increased the Authorized Shares to 1 billion in order to have the flexibility of possible financings in the future but also to pursue acquisitions, particularly manufacturing facilities in Southeast Asia. As part of this potential growth, the Company is looking into listing the Company for trading in overseas markets with an emphasis on South East Asia.


April 18, 2007: Pharm Control Announces New Product Developments (Market Wire)

Pharm Control is proud to announce that the Company is intensely researching and developing a new product that is an all-natural medication to reduce blood pressure for high blood pressure sufferers. The Company hopes to bring this product to market shortly both in Europe and North America were the market for such a product is high. In regard to Shareholder Update dated April 5, 2007, the Company anticipates the name change to Natural Medications Inc. and the new CUSIP number will be completed in the upcoming weeks.


April 5, 2007: Pharm Control Ltd Shareholder Update (M2 PRESSWIRE via COMTEX)

Pharm Control Ltd is announcing its plan to change the Company's name to Natural Medications Inc. The new Corporate name is a better reflection of the Company's mandate of researching and developing non-synthetic medicines.

Management also wishes to advise its shareholders that all existing shares will be exchanged on a one existing share for one new share basis (1 for 1) once the Name Change has been confirmed and the new CUSIP number has been obtained.

It is management's hope that these initiatives taken will combat the recent short selling of the Company's shares.

CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. Tel: +1 212 252 4521 e-mail: pmclinfo@yahoo.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to info@m2.com.


March 22, 2007: Pharm Control Ltd Victim of Short Selling (M2 PRESSWIRE via COMTEX)

Pharm Control Ltd management is in the process of ordering a current Non Objecting Beneficial Owners list (NOBO list) from ADP Investor Communications. This is in response to the various emailssent and calls made to the Company's offices concerning possible short selling of the Company's stock.

The NOBO list shows a more complete and comprehensive shareholder profile than is typically available on a shareholder list provided by a transfer agent. In addition, management will order Depository Trust Corporation (DTC) reports for further examination. Both lists will be utilized to uncover possible short positions.

The NOBO list will be used to determine the naked short position in Pharm Control's common stock. The NOBO list will be compared to the reports from the DTC which contains data regarding all brokers and amounts of shares being held for investors. These lists will be used to get a total amount of shares owned by all shareholders and any naked short positions. The findings will then be reported to the NASD (National Association of Securities Dealers) to take action against the violators of the naked short regulations.

The company will take all necessary action to protect the value of shareholder investments and the steps now being taken exhibit the Company's response to the various emails send and calls made to our offices by investors.

CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. Tel: +1 212 252 4521 e-mail: pmclinfo@yahoo.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to info@m2.com.


February 21, 2007: Pharm Control Plans Listing Changes (Qwoter.com)

The management of Pharm Control has announced plans to have the Company’s stock listed on a higher exchange next year in the United States. Concurrent with an enhanced listing in the USA, the Company plans to apply for listings on European and other international exchanges. Management is anticipating revenue for 2007 to exceed US $18,000,000 with 2008 early projections being in excess of US $50,000,000. Profit margins are anticipated to be in excess of 20%. Pharm Control Vice President, Eugene Kron has stated, “listings on higher and overseas exchanges should increase the profile of the company dramatically.”


February 20, 2007: Pharm Control Anticipates Revenue Growth for the first half of 2007 (Qwoter.com)

Pharm Control estimates that European sales should total US $8,400,000.00 in the first 6 months of operations with further increases anticipated as the company expands into other European markets where natural and homeopathic remedies are readily accepted.


January 30, 2007: Pharm Control Announces the Acquisition of Licensing Rights in Europe (Market Wire)

Pharm Control is proud to announce the acquisition of licenses required to sell its products in Poland and Germany, where natural and homeopathic acceptance of natural solutions is well known. The first trial shipments of pills have been shipped to Germany and Poland and the Company expects that its Control 24™ product will be available on the shelves in both countries by the middle of 2007.


iHub Member Comment on Wal-mart: http://investorshub.advfn.com/boards/read_msg.asp?Message_id=18000672&txt2find=european


January 24, 2007: Pharm Control Announces Preliminary Talks With Wal-Mart (Market Wire)

As part of its continuing efforts to broaden product distribution, Pharm Control has made an application and has had preliminary talks with Wal-Mart to become a new supplier. As part of these discussions the company has been given a Supplier Application Number. The company expects talks to continue this year.


January 23, 2007: Pharm Control Now Trading on the OTC (Market Wire)

Pharm Control is pleased to announce that the company now trades on the OTC pink sheets under the symbol PMCL. The company is focused on the development of natural, no side effect supplements to cure diseases such as Diabetes, high blood pressure and high cholesterol related sicknesses, digestive disorders, liver and kidney diseases. The first product in the development pipeline is Control 24™, a natural product that is focused on the Diabetes and pre-Diabetes market.


Disclaimer

This board, the moderator and assistants are not associated with Pharm Control Ltd. or any firms under contract to promote Pharm Control Ltd.

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Please review the Investors Hub Terms of Service (TOS) for the message posting rules. Posting on internet message boards is not anonymous and you can be held liable for spreading false and misleading information about people and companies. Post at your own risk.

TOS Refresher: http://investorshub.advfn.com/boards/complex_terms.asp


For more information regarding investments and Internet fraud, please visit the SEC web site: http://www.sec.gov/sitemap.shtml and http://www.sec.gov/investor/pubs/cyberfraud.htm

PostSubject
#39795   PMCL: FINRA deleted symbol: Renee 10/29/18 05:07:08 PM
#39794   Irwin Boock Yahoo4 08/17/15 01:08:30 PM
#39793   More Irwin block news today. Yahoo4 08/17/15 01:07:51 PM
#39792   And what does it mean to us stock holders? wittke 03/19/14 07:18:50 AM
#39791   Judge orders Toronto billionaire’s ex-partners to pay millions PhillyPA65 03/19/14 01:33:27 AM
#39790   Decision out? Yahoo4 01/17/14 09:47:28 AM
#39789   OSC - Notice from the Office of the Secretary PhillyPA65 09/17/13 11:26:51 PM
#39788   November 12th,2013 hearing is scheduled by the OSC HAK41 09/17/13 09:32:24 PM
#39787   Booke and DeFreitas Involved in MGLG Shell Scam PhillyPA65 06/29/13 06:16:25 PM
#39786   Irwin Boock, Stanton B.J. Defreitas, Nicolette D. Loisel, PhillyPA65 06/28/13 03:34:55 PM
#39785   Court showdown pits billionaire against ex-partners slob 06/27/13 10:17:37 PM
#39784   hey there PhillyPA65..i found this on another board[MGLG]...seems slob 06/27/13 10:09:26 PM
#39783   There is nothing to do other than a suprabiz2 12/24/12 08:16:26 PM
#39782   I haven't been here in a long, long time. Beardeus 12/18/12 05:22:50 PM
#39781   Volume: 2,500 Todays volume some traiding going on again!!!!//?? wittke 10/25/12 01:03:02 PM
#39780   Alena Dubinsky of Ontario Named as a Relief Defendant PhillyPA65 10/20/12 10:45:29 PM
#39779   Really looks like this compensation is going to happen! Klinsmann 10/16/12 05:17:16 AM
#39778   You have to wait for Irwin Boock, Jason PhillyPA65 10/12/12 04:34:24 PM
#39777   So when and how do we get our wittke 10/12/12 01:15:10 PM
#39776   SEC Litigation Release No. 22499 - September 28, 2012 PhillyPA65 10/12/12 02:35:57 AM
#39775   U.S. SECURITIES AND EXCHANGE COMMISSION Rebel J1 10/12/12 02:07:03 AM
#39774   PHARM CONTROL LTD (PMCL)-OTC Markets wittke 10/11/12 04:04:11 PM
#39773   NEWS NEWS NEW....IRWIN BOOCK SETTLES WITH [SEC]...ALL CURRENT slob 03/21/12 01:46:24 PM
#39772   More News Coverage of OSC - Boock Settlement PhillyPA65 02/20/12 12:28:52 AM
#39771   You mean they can't go to the hookers Cellar2007 02/17/12 12:06:47 AM
#39770   No. The crooks probably spent all of PhillyPA65 02/16/12 10:16:17 PM
#39769   does this mean we'll get paid back? bova80 02/16/12 03:07:16 PM
#39768   OSC Settlement with Irwin Boock PhillyPA65 02/15/12 10:01:15 PM
#39767   teddibear Share slob 02/05/12 08:34:56 PM
#39766   nice catch PhillyPA65... i copied and pasted that slob 02/01/12 12:10:46 PM
#39765   we will have to wait and see,,,i would slob 02/01/12 11:52:50 AM
#39764   That`s the way I see it,if you have wzebra33 02/01/12 09:35:35 AM
#39763   I still have my shares. So how bova80 02/01/12 09:18:13 AM
#39762   The SEC filed a civil lawsuit against these PhillyPA65 01/31/12 11:40:28 PM
#39761   It would cost nothing if you let the wzebra33 01/30/12 09:48:02 AM
#39760   Has anyone with shares sought legal help on stuckme 01/29/12 10:51:56 PM
#39759   after all these years, i still have mine,,i slob 01/28/12 10:00:31 PM
#39758   I'm stuck with my shares. No Buy PhillyPA65 01/28/12 09:28:47 PM
#39757   I don`t know how long or how much wzebra33 01/26/12 02:54:53 PM
#39756   So another three to four years to get wittke 01/26/12 02:07:20 PM
#39755   Thanks Mobiaus for keeping this current..and to all slob 01/24/12 02:39:29 PM
#39754   0. Any amounts paid to the Commission under wzebra33 01/24/12 09:53:52 AM
#39753   http://www.osc.gov.on.ca/en/Proceedings_set_20120119_boocki-defreitas.htm Mobiaus 01/24/12 02:15:56 AM
#39752   Securities and Exchange Commission v. Boock et al PhillyPA65 11/28/11 10:46:49 PM
#39751   http://www.leagle.com/xmlResult.aspx?xmldoc=In%20FDCO%2020111109C25.xml&docbase=CSLWAR3-2007-CUR slob 11/28/11 07:07:15 PM
#39750   FOUND THIS ON THE [MGLG] BOARD.... slob 11/28/11 06:56:34 PM
#39749   Got it. Thanks! PhillyPA65 10/07/11 06:43:13 PM
#39748   hey PhillyPA65,,,see my post #39741..best to you!! slob 10/07/11 05:46:18 AM
#39747   FOLLOW CASE HERE PhillyPA65 10/06/11 07:10:19 PM
#39746   No buy / No sell according to Scottrade. PhillyPA65 10/06/11 06:48:50 PM
PostSubject